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Abstract
Oropharyngeal dysphagia is prevalent in several at-risk populations, including post-stroke patients, patients in intensive care 
and the elderly. Dysphagia contributes to longer hospital stays and poor outcomes, including pneumonia. Early identifica-
tion of dysphagia is recommended as part of the evaluation of at-risk patients, but available bedside screening tools perform 
inconsistently. In this study, we developed algorithms to detect swallowing impairment using a novel accelerometer-based 
dysphagia detection system (DDS). A sample of 344 individuals was enrolled across seven sites in the United States. Dual-
axis accelerometry signals were collected prospectively with simultaneous videofluoroscopy (VFSS) during swallows of 
liquid barium stimuli in thin, mildly, moderately and extremely thick consistencies. Signal processing classifiers were trained 
using linear discriminant analysis and 10,000 random training–test data splits. The primary objective was to develop an 
algorithm to detect impaired swallowing safety with thin liquids with an area under receiver operating characteristic curve 
(AUC) > 80% compared to the VFSS reference standard. Impaired swallowing safety was identified in 7.2% of the thin liquid 
boluses collected. At least one unsafe thin liquid bolus was found in 19.7% of participants, but participants did not exhibit 
impaired safety consistently. The DDS classifier algorithms identified participants with impaired thin liquid swallowing safety 
with a mean AUC of 81.5%, (sensitivity 90.4%, specificity 60.0%). Thicker consistencies were effective for reducing the 
frequency of penetration–aspiration. This DDS reached targeted performance goals in detecting impaired swallowing safety 
with thin liquids. Simultaneous measures by DDS and VFSS, as performed here, will be used for future validation studies.
Keywords Deglutition · Deglutition disorders · Dysphagia · Swallowing · Screening · Devices
Introduction
Individuals with dysphagia are faced with two functional 
concerns: 1, the inability to swallow safely, whereby mate-
rial enters the airway (“penetration–aspiration” [1]); and/or 
2, the inability to swallow efficiently, with residue remaining 
in the pharynx [2, 3]. Impaired swallowing safety is associ-
ated with pneumonia [4] whereas impaired efficiency con-
tributes to the risk of malnutrition [2, 5, 6] and of aspirat-
ing residue after the swallow [7]. Dysphagia is estimated to 
affect 6.7% of hospitalized patients in the United States, with 
an annual attributable cost of $547 million [8]. The burden 
of dysphagia is significant, as shown in a recent analysis 
of the United States Agency for Healthcare Research and 
Quality (AHRQ) Healthcare Cost and Utilization Project 
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National Inpatient Sample database (2009–2013) [9]. The 
estimated additional cost of dysphagia over the study period 
was $16.8 billion. Mean length of stay was 8.8 days for those 
with a dysphagia diagnosis versus 5.0 days for those without. 
Adult patients with dysphagia were 1.7 times more likely 
to die in hospital and 33% more likely to be discharged to a 
post-acute care facility than those without dysphagia. Simi-
lar results from a European study of dysphagia following 
acute ischemic stroke showed that patients with dysphagia 
more frequently had pneumonia (23.1% vs. 1.1%), higher 
mortality (13.6% vs. 1.6%), longer lengths of stay and were 
less frequently discharged to home (19.5% vs. 63.7%) [10].
Stroke practice guidelines recommend early screening 
for swallowing impairment [11–13]. For example, the 2018 
American Heart Association/American Stroke Associa-
tion guidelines for acute ischemic stroke recommend early 
screening to identify dysphagia and, for those in whom risk 
of dysphagia is identified, a swallowing assessment before 
the patient begins eating, drinking or receiving oral medi-
cations [11, 12]. Evidence suggests that formal screening 
programs are more effective at detecting dysphagia than 
informal approaches [14] and are effective for reducing 
pneumonia [15–17]. There is, however, a lack of agreement 
regarding optimal screening methodologies [18–28]. Most 
swallow screening protocols rely on observations by trained 
health care professionals who perform subjective evalua-
tions of non-swallowing tasks (e.g., speech clarity, tongue 
motor function, voice quality and voluntary cough function) 
and swallows of water or other stimuli [23–28]. The detec-
tion of ≥ 1 sign(s) of concern has relatively good sensitivity 
(i.e., > 80%) for identifying patients in whom prior or sub-
sequent videofluoroscopic or endoscopic examinations of 
swallowing confirm the presence of dysphagia or aspiration 
[24, 26–29]. Specificity is reported to range from 49 to 79%.
One acknowledged limitation of existing screening pro-
tocols is their reliance on observation of overt signs of 
aspiration; by definition, this results in poor sensitivity for 
identifying silent aspiration (i.e., aspiration without outward 
signs of difficulty), which is estimated to occur in up to 2/3 
of stroke patients who aspirate [30, 31]. A further limitation 
is that the sensitivity and specificity of screening tests are 
typically determined through comparison of the net (i.e., 
worst) result observed across several screening criteria and 
the worst result obtained across several swallowing tasks in 
the reference assessment. Studies suggest that individuals 
who aspirate do not do so consistently across repeated pres-
entations of similar boluses, even within a single examina-
tion [32, 33]. Such variability challenges the idea that the 
accuracy of screening test results can be properly evaluated 
through comparison to instrumental reference data collected 
on a separate occasion.
For the past few years, we have been developing a 
non-invasive medical device (the Dysphagia Detection 
System, DDS) to detect swallowing impairment based on 
automated machine analysis of cervical accelerometry sig-
nals, trained through direct comparison to simultaneous 
videofluoroscopy [34] (2012). If an accurate and reliable 
device can be developed, concerns regarding the reliance 
of swallow screening on subjective clinical observations 
would be obviated, together with the burden that currently 
exists for training health care professionals to recognize 
signs of swallowing impairment. We report the results of a 
prospective study to develop signal processing algorithms 
for the DDS device, with the ultimate goal of using this 
device to screen swallowing function in adults at risk of 
oropharyngeal dysphagia.
Methods
This study involved prospective collection and classifica-
tion of dual-axis (superior–inferior and anterior–posterior) 
accelerometry signals, collected from the front of the neck 
during swallows of water and of barium stimuli of differ-
ent consistencies. These signals were collected with time-
synchronized videofluoroscopy (VFSS), which was used as 
the clinical reference standard for determining true status 
(safe/unsafe; efficient/inefficient). The study was conducted 
at seven hospitals (six acute care; one inpatient rehabilita-
tion hospital) between November 7, 2013, and March 11, 
2015. The protocol was approved by the Institutional Review 
Board (IRB) of each participating medical center.
Participants
Consenting participants were recruited from a broad popu-
lation of adults considered at risk for non-congenital, non-
surgical, and non-oncologic oropharyngeal dysphagia. The 
population included those with stroke or other brain injury 
aged ≥ 21 years and other inpatients or outpatients with dys-
phagia risk aged ≥ 50 years. Exclusion criteria included the 
presence of a nasogastric feeding tube; neck surgery (includ-
ing tracheotomy within the past year, resection for oral or 
pharyngeal cancer, radical neck dissection, cervical spine 
surgery, carotid endarterectomy, orofacial reconstruction, 
pharyngoplasty, or thyroidectomy; routine tonsillectomy 
and/or adenoidectomy were not excluded); non-surgical 
trauma to the neck resulting in musculoskeletal or nerve 
injury; or radiation to the neck. These exclusions were 
applied due to the possibility that these conditions might 
alter or interfere with the ability to collect swallowing accel-
erometry signals using a sensor placed on the surface of the 
neck. Participants had to have sufficient cognitive function 
to be able to comply with study procedures.
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Investigational Device Description
The DDS is a portable, non-invasive device consisting of 
a dual-axis accelerometer (bandwidth up to 1600 Hz) con-
tained in the plastic housing of a sensor unit that is attached 
by a single-use, disposable fixation unit to the front of a 
patient’s neck in midline, just below the palpable lower bor-
der of the thyroid cartilage. Vibrations are detected in the 
superior–inferior and anterior–posterior axes. The sensor 
unit was connected via a cable to an A/D converter (12-
bit resolution, 10 kHz sampling frequency), which in turn 
was connected to a laptop computer where the signal was 
recorded.
Procedures
The data collection protocol began by asking participants 
to swallow six comfortably sized sips of water from a cup. 
These water data were collected to demonstrate equivalence 
of the DDS signal profiles for water and thin-barium stimuli 
and will not be further discussed in this manuscript. The 
protocol continued with six sips of thin liquid barium, fol-
lowed by three sips each of mildly thick, moderately thick 
and extremely thick barium. The thin and mildly thick liq-
uids were taken by sip from 7-ounce cups containing 4 oz 
of liquid. The moderately thick and extremely thick barium 
were taken by teaspoon. Sip volume was measured based on 
pre- and post-sip cup weights. The thickened stimuli were 
prepared by mixing a powdered xanthan gum thickener 
(Nestlé  Resource®  ThickenUp® Clear™) with the thin liquid 
barium powder (Bracco  Varibar® Thin) and water in a 20% 
w/v barium concentration according to standard recipes (see 
Online Appendix for more details). Lateral view videofluor-
oscopy (recorded at 30 frames/second) and simultaneous 
accelerometry signals were captured on a laptop computer. 
Stopping rules were applied for safety with testing of a par-
ticular stimulus discontinued after two penetration–aspira-
tion events and the entire protocol terminated after a total of 
five penetration–aspiration events.
Videofluoroscopy Rating
All videofluoroscopy records were analyzed in a central 
lab utilizing a standard operating procedure (see Online 
Appendix for more details). Each bolus recording was ran-
domly assigned to be assessed independently by two raters 
who were masked to the identity and diagnosis of the par-
ticipant, study site, the bolus consistency and order of the 
bolus within the data collection sequence. The rating for 
each bolus included a measure of swallowing safety scored 
according to the 8-point Penetration–Aspiration Scale [1]; 
and pixel-based measures of residue severity taken on the 
last frame of each swallow [35]. When necessary, a meeting 
of at least three raters was convened to resolve discrepancies 
by consensus. If the raters concurred that visualization of the 
structures necessary for a particular rating was obscured, 
the feature in question was documented as not-rateable 
and became a missing data point, resulting in exclusion 
of that record from the data available for algorithm train-
ing. Confirmed ratings were transformed to binary scores 
as follows: for swallowing safety, 1–2 versus 3–8 on the 
Penetration–Aspiration Scale [1]; inefficiency was opera-
tionally defined as the presence of residue at the end of any 
swallow, filling ≥ 50% of the valleculae and/or the pyriform 
sinuses [36]. A participant was considered to have impaired 
swallowing safety (or efficiency) on a given consistency if 
at least one bolus in the series for that stimulus was rated as 
unsafe or inefficient, respectively.
Accelerometry Signal Processing and Classifier 
Development
The classifier development path is illustrated in Fig. 1. Dur-
ing preprocessing, the accelerometry signals were filtered 
first with a second-order high-pass Butterworth filter (0.1 Hz 
corner frequency) and then with a low-pass filter (1000 Hz 
corner frequency). This was followed by automated signal 
segmentation to isolate regions of swallow activity within 
each signal recording and feature extraction for analysis. 
Several well-established models for training classifiers were 
explored, including Support Vector Machine, Random For-
est, Quadratic Discriminant Analysis and Linear Discrimi-
nant Analysis (LDA) [37]. Ultimately, a regularized LDA 
model approach using an equal covariance matrix for all 
estimated classes was selected because it had the most robust 
performance and a low risk of over-fitting to the training 
data [37]. Classifier models were built and validated in an 
iterative fashion using internal repeated random sub-sam-
pling (also known as the Monte Carlo method [38, 39]). 
From the whole set of data, 20% of the participants were set 
aside as a validation set and the signals from the remaining 
80% of participants were used to train the classifier (train-
ing set). The trained classifier was then used to estimate the 
classes (i.e., safe, unsafe; efficient, inefficient) of the cases 
in the validation set that were previously unseen by the clas-
sifier. These results were then compared to the true classes 
obtained from the videofluoroscopy analysis. This process 
was repeated 10,000 times with randomly selected validation 
and training sets and the classifier was re-generated dur-
ing each iteration with the new training set. In this manner, 
each independent iteration could be considered analogous 
to training the device on a sample of approximately 244 
individuals, representing 80% of individuals in a particular 
cohort in a particular setting, before being applied unsu-
pervised to the remaining 20% of unseen patients (approxi-
mately 61) in that cohort and setting. Random splitting of the 
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data was stratified by the participant’s status derived from 
the VFSS results; thus, all boluses from a given participant 
were either in the training or the validation set on a given 
iteration. The area under the curve (AUC) measures of the 
receiver operator curve (ROC) from each of the independent 
validation sets across all runs were averaged to provide the 
mean and standard deviation of the AUC for the classifier at 
the bolus level. The large number of iterations (i.e., 10,000) 
was chosen in light of the high standard deviation of the 
resulting AUC.
In total, six different LDA classifiers were developed: 
three algorithms to detect impaired swallowing safety (thin 
liquids; mildly thick liquids; moderately thick liquids) and 
three to detect impaired swallowing efficiency (thin, mildly 
and moderately thick liquids). Given the limited availability 
of impaired swallowing safety data for the moderately thick 
consistency, it was decided to use combined moderately and 
extremely thick stimuli in the training set of the moderately 
thick safety classifier; the corresponding validation sets 
included only moderately thick consistency swallows.
Analysis of the cumulative frequency of impaired swal-
lowing safety by bolus number, across the series of thin liq-
uid boluses administered, showed new occurrences beyond 
the first bolus (7.5%) to the second (15%), third (18.5%) 
and fourth bolus (22.2%), with relatively small incremen-
tal detection rates on the fifth (23.4%) and sixth (25.6%) 
boluses. Given this finding, the mean predicted probabil-
ity of impairment was summarized at the participant level 
using up to four boluses for thin and up to three boluses 
for other consistencies. The ROC at participant level was 
obtained by comparing these mean predicted probabilities 
with the participant level class label obtained using the “at 
least one positive” roll-up rule on the VFSS binary data. 
Thus, if the VFSS showed a problem on at least one bolus of 
a given consistency, that participant was classified as having 
impaired swallowing function on that consistency.
Results
Participants
A total of 344 patients consented to participate in the study. 
Of these, 12 were excluded based on protocol requirements 
(see Fig. 2). Videofluoroscopy was performed in 332 partici-
pants for whom the demographic characteristics are summa-
rized in Table 1. Complete VFSS and DDS signal data were 
available for at least 2 boluses for 305 participants. There 
were no serious adverse events related to the device or the 
swallowing trial protocol.
Prevalence of Impaired Swallowing Safety 
and Efficiency in the Study Population
Videofluoroscopy data for 1730 thin, 872 mildly thick, 833 
moderately thick and 794 extremely thick boluses were ana-
lyzed. Table 2 shows the frequencies of unsafe swallows and 
efficiency issues by consistency at both the bolus and the 
participant levels. The number of available data points dif-
fers for the safety versus efficiency ratings because the vis-
ibility of the airway (necessary for rating safety) on a given 
recording may have differed from visibility of the vallecu-
lae and pyriform sinuses required for rating efficiency. Post 
hoc examination of the frequency distribution of Penetra-
tion–Aspiration Scale rating data by the central laboratory 
showed that 23 participants (i.e., 7.5%) had silent aspiration 
(i.e., PAS scores of 8) on at least one thin liquid bolus. The 
participant-level prevalence of silent aspiration dropped to 
Fig. 1  Flowchart showing the process used for developing classifier 
algorithms
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Fig. 2  Overview of participants 
in the study
Table 1  Demographic 
characteristics of the 
subjects who underwent 
videofluoroscopy by diagnostic 
subgroup
The data are shown according to the following convention x ± s represents the mean ± one standard devia-
tion
N Stroke Other brain injury Other, aged ≥ 50 Combined
(N = 107) (N = 18) (N = 207) (N = 332)
Sex 332
 Women 48 (45%) 4 (22%) 113 (55%) 165 (50%)
 Men 59 (55%) 14 (78%) 94 (45%) 167 (50%)
Age 332 70 ± 14 67 ± 11 73 ± 11 72 ± 12
VFSS recorded 332
Table 2  Prevalence of impaired 
swallowing safety and impaired 
swallowing efficiency at the 
bolus and subject level, by 
stimulus type
Stimulus consistency Number of data points 
available
Impaired safety Impaired efficiency
Boluses Participants Bolus level Participant 
level
Bolus level Participant 
level
n % n % n % n %
Thin (1–6 boluses) 1730 305 125 7.2 70 23.0 115 6.7 60 19.7
Mildly thick 872 302 51 5.9 42 13.9 86 9.9 54 17.9
Moderately thick 833 281 17 2.0 14 5.0 75 8.9 51 18.2
Extremely thick 794 268 11 1.4 10 3.7 67 8.4 48 17.9
Table 3  Classifier accuracy 
for detecting swallow safety 
problems by consistency
a Data for the extremely thick consistency were included in the training set for the moderately thick safety 
model
Consistency Bolus level AUC (%) 
mean ± SD
Participant level AUC 
(%) mean ± SD
Sensitivity (%) 
mean ± SD
Specific-
ity (%) 
mean ± SD
Thin 80.9 ± 5.9 81.5 ± 6.1 90.4 ± 7.7 60.0 ± 7.8
Mildly thick 83.9 ± 5.6 83.6 ± 5.9 92.7 ± 8.7 59.9 ± 7.5
Moderately  thicka 78.9 ± 11.9 79.7 ± 15.1 89.1 ± 22.0 59.6 ± 7.6
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5.3% on the mildly thick liquids and < 1% on the moderately 
and extremely thick liquids.
Accuracy of Classifiers
Tables 3 and 4 summarize the estimated accuracy of the 
DDS classifiers for swallowing safety and efficiency, respec-
tively. For the primary outcome of detecting impaired swal-
lowing safety on thin liquids, a mean AUC of 80.9% on the 
ROC was obtained at the bolus level. At the participant level, 
the mean AUC was 81.5%, with sensitivity (i.e., true posi-
tive rate) of 90.4% and specificity (i.e., true negative rate) 
of 60.0%. Classifier performance was similar for detecting 
impaired swallowing safety on thicker consistencies. The 
efficiency classifiers achieved sensitivities of ~ 80% and spe-
cificities of 60% across the consistencies tested.
Discussion
In this study, signal processing classifiers were trained 
using a large dataset collected from a heterogeneous sample 
of individuals with risk for dysphagia. As the first step in 
identifying dysphagia, it is desirable for swallow screening 
methods to have wide applicability and accuracy in patient 
populations with dysphagia risk related to varied medical 
conditions and for whom the pathophysiological mecha-
nisms leading to impaired swallowing safety or efficiency 
may be heterogeneous. Within this broader objective, the 
inclusion criteria for this particular study excluded individu-
als with oncological, structural or congenital etiologies of 
dysphagia, and the definition of impaired swallowing safety 
was set conservatively as a Penetration–Aspiration Scale 
score ≥ 3.
The DDS classifiers developed in this study were able 
to identify impaired swallowing safety on thin liquid swal-
lows with high accuracy. In clinical practice, the achieved 
classifier performance results would translate to failure 
to identify impaired swallowing safety in 10% of patients 
and over-detection in 40%. This degree of over-detection is 
acceptable in screening, provided that referral for assessment 
to verify the patient’s swallowing status occurs in a timely 
manner [40, 41].
Several differences between the classifier results of this 
study and commonly used swallow screening protocols 
should be noted. First, the results for thin liquids in this 
study were obtained using a small number of sips (i.e., 4). 
Second, the results obtained in this project are consistency 
specific. It is encouraging that similar algorithm perfor-
mance was achieved for detecting impaired swallowing 
safety across a range of consistencies. The current data 
are consistent with previous studies in showing reduced 
rates of penetration–aspiration with thickened liquids 
[42–45]. However, this also meant that a smaller number 
of impaired signal examples were available for algorithm 
training for moderately thick liquids. Additionally, proto-
col-mandated stopping rules did not permit more severely 
affected participants to receive the thicker consistencies.
Our data corroborate observations from previous stud-
ies that the occurrence of penetration–aspiration on a 
given consistency varies from bolus to bolus in individu-
als with impaired swallowing safety [32, 33]. This finding 
has two major implications: (1) more than one swallow 
should be assessed to determine if a patient can swallow 
a given consistency safely; and (2) validation of the accu-
racy of any method for detecting swallowing impairment at 
the bedside requires direct comparison to a simultaneous 
reference standard rather than a reference test performed 
at a different time [26–28]. An advantage of using direct 
comparison to simultaneous videofluoroscopy is that we 
were able to include verified examples of silent aspiration 
in the training sets of unsafe swallows in this study.
Given the overall objective of developing a swallow 
screening instrument that would have broad utility to iden-
tify impaired swallowing safety in a heterogeneous sample 
of patients, no attempts were made to stratify the data by 
PAS severity beyond the binary groupings of < versus ≥ 3. 
Similarly, we did not limit the examples of impaired swal-
lowing safety to cases of airway invasion before, during or 
after the swallow. Although previous studies have identi-
fied links between specific swallowing parameters (such 
as measures of hyolaryngeal excursion) and the features 
of swallowing accelerometry signals [46, 47], the algo-
rithm training process in this study allowed for a variety of 
pathophysiological mechanisms to be included in the sub-
set of cases that the device learned to identify as impaired. 
The study is not powered to allow stratification by severity, 
Table 4  Classifier accuracy for 
detecting swallow efficiency 
problems by consistency
Consistency Bolus level AUC (%) 
mean ± SD
Participant level AUC 
(%) mean ± SD
Sensitivity (%) 
mean ± SD
Specific-
ity (%) 
mean ± SD
Thin 76.7 ± 6.4 77.7 ± 7.5 82.3 ± 11.0 59.2 ± 7.9
Mildly thick 80.1 ± 6.0 78.0 ± 7.7 82.4 ± 11.0 59.6 ± 7.9
Moderately thick 73.3 ± 7.1 71.9 ± 8.3 79.3 ± 11.7 59.3 ± 8.2
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timing or mechanism of swallowing impairment; strati-
fications of this sort would require much larger datasets 
with adequate representation of the different groupings 
of interest.
The majority of swallow screening protocols in current 
use focus on signs of impaired safety and risk of aspiration, 
without consideration of swallow efficiency. Given this, it 
is encouraging that sensitivities and specificities of ~ 80 and 
60%, respectively, were also obtained for the separate clas-
sifier algorithms developed to detect impaired swallowing 
efficiency using the DDS. Individuals who have impaired 
swallowing efficiency may require more time to complete 
a meal, and are thought to be at risk both for post-swallow 
aspiration and malnutrition [6, 36]. Our data show that swal-
lowing inefficiency is a common finding. Furthermore, the 
data suggest that residue can be common after swallows 
of thin liquids. We found no evidence to support the wide-
spread assumption that residue increases with thicker stimuli 
(Table 2). This finding may be explained by the use of a 
xanthan gum thickener rather than starch-based thickeners 
[48], which are commonly used in clinical practice.
Conclusion
In this study, we generated accelerometry signal classifi-
cation algorithms to detect impaired swallowing safety in 
patients at risk for dysphagia with high accuracy using a 
pragmatic DDS protocol involving a series of four thin liquid 
sips. Additional algorithms to detect impaired swallowing 
safety with thicker consistencies and to detect impaired swal-
lowing efficiency across the range from thin to moderately 
thick liquids were also developed. Development of these 
algorithms represents a critical first step in the process of 
developing an accurate, non-invasive, accelerometry-based 
device for swallow screening. The next step will be to vali-
date these algorithms in a prospective study using a novel 
patient sample. Based on the current study results, a valida-
tion study of this sort will require simultaneous collection 
of screening and reference data. If such a validation study 
were to be performed with a fixed design in a population 
with 60% participant-level prevalence of impaired swallow-
ing safety on thin liquids, with at least 30% of the thin liquid 
swallows displaying the swallowing safety problem in those 
participants, power calculations based on the results of this 
study suggest that a minimum sample of 500–600 partici-
pants would be required, assuming performance targets of 
86% sensitivity, 60% specificity and 90% power. If accurate 
device performance can be confirmed for detecting impaired 
swallowing safety and/or impaired swallowing efficiency on 
a range of liquid consistencies in the broad population of 
individuals at risk for dysphagia, comparisons to current 
screening methods, which rely on subjective clinical obser-
vations of swallowing difficulty, will also be warranted.
Acknowledgements The authors would like to thank Maryam Kadjar 
Olesen, Head of Global Clinical Operations at Nestlé Health Science 
for her contributions to the study. The authors would like to thank 
Paula Kamman, Nancy Schurhammer and Ryan Ping from RCRI 
Regulatory and Clinical Research Institute, Minneapolis, MN for their 
contributions to oversight of data collection, database management 
and quality control. The authors would like to thank Liza Blumenfeld 
(Scripps Memorial Hospital, La Jolla, CA), Gintas Krisciunas (Boston 
Medical Centre, Boston, MA), Andrea Tobochnik (Bronson Health-
care, Kalamazoo, MI), Ka Lun Tam (Bloorview Research Institute, 
Toronto), Melanie Peladeau-Pigeon, Melanie Tapson, Talia Wolkin 
and Navid Zohouri-Haghian (Toronto Rehabilitation Institute—Uni-
versity Health Network) for their contributions to data acquisition. The 
authors would like to thank Carly Barbon, Vivian Chak, Amy Dhindsa, 
Robbyn Draimin, Natalie Muradian, Ahmed Nagy, Ashwini Nama-
sivayam-MacDonald, Sonya Torreiter, Teresa Valenzano and Ashley 
Waito, (Toronto Rehabilitation Institute—University Health Network) 
for their contributions to videofluoroscopy rating. The authors would 
like to thank Jaakko Lähteenmäki, Juha Pajula and co-workers of VTT 
Technical Research Centre of Finland Ltd. for their contributions to 
data analysis and input on technical implementation considerations. 
The authors would like to thank Tom Chau, Helia Mohammadi, Ali 
Akbar-Samadani and Ka Lun Tam from the PRISM lab, Bloorview 
Research Institute, Toronto, for their contributions to data analysis. 
The authors would like to thank Munshiimran Hossain and Andrea Hita 
from Cytel Inc. for their contributions to data analysis.
Author Contributions Catriona M. Steele is the guarantor of the paper 
and takes responsibility for the integrity of the work as a whole, from 
inception to published article. The study was designed by Catriona 
M. Steele & Nestlé (co-authors NM, MJ). Classifier development and 
analysis was conducted by Nestlé (co-authors NM, MJ) with VTT (co-
authors KM, HP), Cytel (co-author RM) and the Prism Lab, Bloorview 
Research Institute, Toronto. Data were collected by site investigator 
teams (co-authors SLB, KBT, SL, LFR, and NBS). The statistical 
analyses were performed by Cytel (co-author RM) according to the 
statistical analysis plan. The study was guided by an advisory group 
who interpreted the results (co-authors CMS, PMB, LBG, RLH, DL, 
KRL, and AM). Preparation, review and approval of the manuscript 
were performed by all co-authors.
Funding The study was sponsored by Nestec S.A., Vevey, Switzerland, 
through contracts negotiated through a contract research organization 
with participating hospitals and directly with Cytel, Massachusetts, 
USA; VTT Technical Research Centre of Finland, Espoo, Finland; 
and University Health Network, Toronto. The sponsor was responsible 
for site management, data collection, database management and data 
archiving activities.
Compliance with Ethical Standards 
Conflict of interest Philip M. Bath is Stroke Association Professor 
of Stroke Medicine and a NIHR Senior Investigator. He is a member 
of a Nestlé Advisory Board for which he receives an honorarium and 
travel expenses. He is a consultant to Nestec SA and for Phagenesis 
Ltd (which is partly owned by Nestlé), has given education talks for 
them, was Chief Investigator of their STEPS trial, is Co-Chief Inves-
tigator of their PhEED trial, and receives an honorarium and travel 
expenses for this work. Larry B. Goldstein is the Ruth L. Works Pro-
fessor and Chairman, Department of Neurology and Co-Director, 
Kentucky Neuroscience Institute at the University of Kentucky. He is 
705C. M. Steele et al.: Development of a Non-invasive Device for Swallow Screening in Patients at Risk of Oropharyngeal…
1 3
a member of a Nestlé Advisory Board for which he receives an hono-
rarium and travel expenses. Richard L. Hughes is Professor of Neurol-
ogy and participates in clinical research sponsored by the NIH and 
Industry. He is a member of a Nestle Advisory Board for which he 
receives an honorarium and travel expenses. Kennedy R. Lees is Pro-
fessor of Cerebrovascular Medicine at the Institute of Cardiovascular 
and Medical Sciences, University of Glasgow. He is a consultant for 
Nestec SA. He has also received consulting fees or research funding 
from the American Heart Association, Applied Clinical Intelligence, 
Boehringer Ingelheim, EVER NeuroPharma, Hilicon, Parexel, Trans-
lation Medical Academy, University Newcastle (Australia), European 
Union, IQVIA, National Institutes of Health (USA), Novartis, and Su-
novion. Dana Leifer is Associate Professor of Neurology and an NIH 
StrokeNet Principal Investigator. He is a member of a Nestlé Advisory 
Board for which he receives an honorarium. Atte Meretoja has con-
sulted for Nestec SA and Phagenesis Ltd. He is a member of a Nestlé 
Advisory Board for which he receives an honorarium and travel ex-
penses. Luis F. Riquelme is a member of the board of directors for the 
International Dysphagia Diet Standardisation Initiative. Catriona M. 
Steele has served on Nestlé expert panels for which she has received 
honoraria and travel expenses. She is an NIH-funded principal inves-
tigator and a member of the board of directors for the International 
Dysphagia Diet Standardisation Initiative. Nancy B. Swigert is a paid 
consultant for Nestlé and serves on the Medical Advisory Board of the 
National Foundation on Swallowing Disorders. Natalia Muehlemann 
and Michael Jedwab are full-time employees of Nestlé Health Science, 
Nestec SA. Juha M. Kortelainen and Harri Pölönen are employees of 
VTT Technical Research Centre of Finland Ltd. Rajat Mukherjee is an 
employee of Cytel Inc. Susan L. Brady, Kayla Brinkman Theimer and 
Susan Langmore declare no conflicts of interest.
Ethical Approval The protocol was approved by the Institutional 
Review Board (IRB) of each participating medical center.
OpenAccess This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://creat iveco 
mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
 1. Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A 
penetration-aspiration scale. Dysphagia. 1996;11:93–8.
 2. Rofes L, Arreola V, Almirall J, Cabre M, Campins L, Garcia-Peris 
P, Speyer R, Clave P. Diagnosis and management of oropharyn-
geal Dysphagia and its nutritional and respiratory complications 
in the elderly. Gastroenterol Res Pract. 2011;2011:818979.
 3. Clave P, Shaker R. Dysphagia: current reality and scope of the 
problem. Nat Rev Gastroenterol Hepatol. 2015;12:259–70.
 4. Pikus L, Levine MS, Yang YX, Rubesin SE, Katzka DA, Laufer 
I, Gefter WB. Videofluoroscopic studies of swallowing dysfunc-
tion and the relative risk of pneumonia. AJR Am J Roentgenol. 
2003;180:1613–6.
 5. Carrion S, Cabre M, Monteis R, Roca M, Palomera E, Serra-Prat 
M, Clave P. Prevalence and association between oropharyngeal 
Dysphagia and malnutrition in patients hospitalized in an acute 
geriatric unit (AGU). Dysphagia. 2011;26(4):479.
 6. Carrion S, Cabre M, Monteis R, Roca M, Palomera E, Serra-Prat 
M, Rofes L, Clave P. Oropharyngeal Dysphagia is a prevalent risk 
factor for malnutrition in a cohort of older patients admitted with 
an acute disease to a general hospital. Clin Nutr. 2015;34:436–42.
 7. Molfenter SM, Steele CM. The relationship between residue and 
aspiration on the subsequent swallow: an application of the nor-
malized residue ratio scale. Dysphagia. 2013;28(4):494–500.
 8. Altman KW, Yu GP, Schaefer SD. Consequence of Dysphagia 
in the hospitalized patient: impact on prognosis and hospital 
resources. Arch Otolaryngol Head Neck Surg. 2010;136:784–9.
 9. Patel DA, Krishnaswami S, Steger E, Conover E, Vaezi MF, 
Ciucci MR, Francis DO. Economic and survival burden of Dys-
phagia among inpatients in the United States. Dis Esophagus. 
2018;31:1–7.
 10. Arnold M, Liesirova K, Broeg-Morvay A, Meisterernst J, 
Schlager M, Mono ML, El-Koussy M, Kagi G, Jung S, Sarikaya 
H. Dysphagia in acute stroke: incidence, burden and impact on 
clinical outcome. PLoS ONE. 2016;11:e0148424.
 11. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bam-
bakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, 
Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, 
Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell 
DL, American Heart Association Stroke C. 2018 guidelines for 
the early management of patients with acute ischemic stroke: 
a Guideline for Healthcare Professionals from the Ameri-
can Heart Association/American Stroke Association. Stroke. 
2018;49:e46–110.
 12. Smith EE, Kent DM, Bulsara KR, Leung LY, Lichtman JH, 
Reeves MJ, Towfighi A, Whiteley WN, Zahuranec DB, Ameri-
can Heart Association Stroke C. Effect of Dysphagia screening 
strategies on clinical outcomes after stroke: a systematic review 
for the 2018 guidelines for the early management of patients with 
acute ischemic stroke. Stroke. 2018;49:e123–8.
 13. Boulanger JM, Lindsay MP, Gubitz G, Smith EE, Stotts G, Foley 
N, Bhogal S, Boyle K, Braun L, Goddard T, Heran M, Kanya-
Forster N, Lang E, Lavoie P, McClelland M, O’Kelly C, Pageau P, 
Pettersen J, Purvis H, Shamy M, Tampieri D, vanAdel B, Verbeek 
R, Blacquiere D, Casaubon L, Ferguson D, Hegedus Y, Jacquin 
GJ, Kelly M, Kamal N, Linkewich B, Lum C, Mann B, Milot 
G, Newcommon N, Poirier P, Simpkin W, Snieder E, Trivedi A, 
Whelan R, Eustace M, Smitko E, Butcher K, Acute Stroke Man-
agement Best Practice Writing G, the Canadian Stroke Best P, 
Quality Advisory C, in collaboration with the Canadian Stroke 
C, the Canadian Association of Emergency P: Canadian Stroke 
Best Practice Recommendations for Acute Stroke Management: 
Prehospital, Emergency Department, and Acute Inpatient Stroke 
Care, 6th edn., Update 2018. Int J Stroke: 1747493018786616, 
2018.
 14. Sherman V, Flowers H, Kapral MK, Nicholson G, Silver F, 
Martino R. Screening for Dysphagia in adult patients with 
stroke: assessing the accuracy of informal detection. Dysphagia. 
2018;33(5):662–9.
 15. Lakshminarayan K, Tsai AW, Tong X, Vazquez G, Peacock JM, 
George MG, Luepker RV, Anderson DC. Utility of Dysphagia 
screening results in predicting poststroke pneumonia. Stroke. 
2010;41:2849–54.
 16. Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S. For-
mal Dysphagia screening protocols prevent pneumonia. Stroke. 
2005;36:1972–6.
 17. Titsworth WL, Abram J, Fullerton A, Hester J, Guin P, Waters 
MF, Mocco J. Prospective quality initiative to maximize Dyspha-
gia screening reduces hospital-acquired pneumonia prevalence in 
patients with stroke. Stroke. 2013;44:3154–60.
 18. Ramsey DJ, Smithard DG, Kalra L. Can pulse oximetry or a 
bedside swallowing assessment be used to detect aspiration after 
stroke? Stroke. 2006;37:2984–8.
 19. Bours GJ, Speyer R, Lemmens J, Limburg M, de Wit R. Bedside 
screening tests vs. videofluoroscopy or fibre optic endoscopic 
706 C. M. Steele et al.: Development of a Non-invasive Device for Swallow Screening in Patients at Risk of Oropharyngeal…
1 3
evaluation of swallowing to detect Dysphagia in patients 
with neurological disorders: systematic review. J Adv Nurs. 
2009;65:477–93.
 20. Donovan NJ, Daniels SK, Edmiaston J, Weinhardt J, Summers 
D, Mitchell PH, American Heart Association Council on Cardio-
vascular N, Stroke C. Dysphagia screening: state of the art: invi-
tational conference proceeding from the State-of-the-Art Nurs-
ing Symposium, International Stroke Conference 2012. Stroke. 
2013;44:e24–31.
 21. O’Horo JC, Rogus-Pulia N, Garcia-Arguello L, Robbins J, Safdar 
N. Bedside diagnosis of Dysphagia: a systematic review. J Hosp 
Med. 2015;10:256–65.
 22. Kertscher B, Speyer R, Palmieri M, Plant C. Bedside screen-
ing to detect oropharyngeal Dysphagia in patients with neuro-
logical disorders: an updated systematic review. Dysphagia. 
2014;29:204–12.
 23. Brodsky MB, Suiter DM, Gonzalez-Fernandez M, Michtalik HJ, 
Frymark TB, Venediktov R, Schooling T. Screening accuracy for 
aspiration using bedside water swallow tests: a systematic review 
and meta-analysis. Chest. 2016;150:148–63.
 24. Daniels SK, Anderson JA, Willson PC. Valid items for screen-
ing Dysphagia risk in patients with stroke: a systematic review. 
Stroke. 2012;43:892–7.
 25. Steele CM, Molfenter SM, Bailey GL, Cliffe Polacco R, Waito 
AA, Zoratto DCBH, Chau T. Exploration of the utility of a brief 
swallow screening protocol with comparison to concurrent vide-
ofluoroscopy. Can J Speech-Lang Pathol Audiol. 2011;35:228–42.
 26. Martino R, Silver F, Teasell R, Bayley M, Nicholson G, Streiner 
DL, Diamant NE. The Toronto Bedside Swallowing Screening 
Test (TOR-BSST): development and validation of a Dysphagia 
screening tool for patients with stroke. Stroke. 2009;40:555–61.
 27. Suiter DM, Sloggy J, Leder SB. Validation of the Yale Swallow 
Protocol: a prospective double-blinded videofluoroscopic study. 
Dysphagia. 2014;29:199–203.
 28. Trapl M, Enderle P, Nowotny M, Teuschl Y, Matz K, Dachen-
hausen A, Barinin M. Dysphagia bedside screening for acute-
stroke patients: the Gugging swallowing screen. Stroke. 
2007;38:2948–52.
 29. Clave P, Arreola V, Romea M, Medina L, Palomera E, Serra-Prat 
M. Accuracy of the volume-viscosity swallow test for clinical 
screening of oropharyngeal Dysphagia and aspiration. Clin Nutr. 
2008;27:806–15.
 30. Horner J, Massey EW. Silent aspiration following stroke. Neurol-
ogy. 1988;38:317–9.
 31. Daniels SK, Brailey K, Priestly DH, Herrington LR, Weisberg 
LA, Foundas AL. Aspiration in patients with acute stroke. Arch 
PhysMed Rehabil. 1998;79:14–9.
 32. Power ML, Hamdy S, Goulermas JY, Tyrrell PJ, Turnbull I, 
Thompson DG. Predicting aspiration after hemispheric stroke 
from timing measures of oropharyngeal bolus flow and laryngeal 
closure. Dysphagia. 2009;24:257–64.
 33. Bath PM, Scutt P, Love J, Clave P, Cohen D, Dziewas R, Iversen 
HK, Ledl C, Ragab S, Soda H, Warusevitane A, Woisard V, 
Hamdy S. Swallowing treatment using pharyngeal electrical 
stimulation trial I: pharyngeal electrical stimulation for treatment 
of Dysphagia in subacute stroke: a randomized controlled trial. 
Stroke. 2016;47:1562–70.
 34. Steele CM, Sejdic E, Chau T. Noninvasive detection of thin-liquid 
aspiration using dual-axis swallowing accelerometry. Dysphagia. 
2013;28(1):105–12.
 35. Pearson WG Jr, Molfenter SM, Smith ZM, Steele CM. Image-
based measurement of post-swallow residue: the normalized resi-
due ratio scale. Dysphagia. 2013;28:167–77.
 36. Eisenhuber E, Schima W, Schober E, Pokieser P, Stadler A, 
Scharitzer M, Oschatz E, Eisenhuber E, Schima W, Schober E, 
Pokieser P, Stadler A, Scharitzer M, Oschatz E. Videofluoroscopic 
assessment of patients with Dysphagia: pharyngeal retention 
is a predictive factor for aspiration. AJR Am J Roentgenol. 
2002;178:393–8.
 37. Hastie T, Tibshirani R, Friedman J. The elements of statistical 
learning: data mining, inference and prediction. 2nd ed. New 
York: Springer; 2001.
 38. Simon R. Resampling strategies for model assessment and selec-
tion. In: Dubitzky W, Granzow M, Berrar D, editors. Funda-
mentals of data mining in genomics and proteomics. New York: 
Springer; 2007.
 39. Remesan R, Mathew J. Model data selection and data pre-process-
ing approaches. Hydrological data driven modelling: a case study. 
New York: Springer; 2014. p. 41–70.
 40. Swets JA. The science of choosing the right decision threshold in 
high-stakes diagnostics. Am Psychol. 1992;47:522–32.
 41. Samuelson FW. Inference based on diagnostic measures from 
studies of new imaging devices. Acad Radiol. 2013;20:816–24.
 42. Logemann JA, Gensler G, Robbins J, Lindblad AS, Brandt D, 
Hind JA, Kosek S, Dikeman K, Kazandjian M, Gramigna GD, 
Lundy D, McGarvey-Toler S, Miller Gardner PJ. A randomized 
study of three interventions for aspiration of thin liquids in 
patients with dementia or Parkinson’s disease. J Speech Lang Hear 
Res. 2008;51:173–83.
 43. Leonard RJ, White C, McKenzie S, Belafsky PC. Effects of bolus 
rheology on aspiration in patients with Dysphagia. J Acad Nutr 
Diet. 2014;114:590–4.
 44. Steele CM, Alsanei WA, Ayanikalath S, Barbon CE, Chen J, 
Cichero JA, Coutts K, Dantas RO, Duivestein J, Giosa L, Han-
son B, Lam P, Lecko C, Leigh C, Nagy A, Namasivayam AM, 
Nascimento WV, Odendaal I, Smith CH, Wang H. The influence 
of food texture and liquid consistency modification on swallow-
ing physiology and function: a systematic review. Dysphagia. 
2015;30:2–26.
 45. Newman R, Vilardell N, Clave P, Speyer R. Effect of bolus viscos-
ity on the safety and efficacy of swallowing and the kinematics of 
the swallow response in patients with oropharyngeal Dysphagia: 
White Paper by the European Society for Swallowing Disorders 
(ESSD). Dysphagia. 2016;31:232–49.
 46. Zoratto DCBH, Chau T, Steele CM. Hyolaryngeal excursion as the 
physiological source of swallowing accelerometry signals. Physiol 
Meas. 2010;31:843–56.
 47. Dudik JM, Kurosu A, Coyle JL, Sejdic E. Dysphagia and its 
effects on swallowing sounds and vibrations in adults. Biomed 
Eng Online. 2018;17:69.
 48. Vilardell N, Rofes L, Arreola V, Speyer R, Clave P. A compara-
tive study between modified starch and Xanthan Gum thick-
eners in post-stroke oropharyngeal Dysphagia. Dysphagia. 
2016;31:169–79.
Catriona M. Steele PhD, CCC-SLP, SLP(C)
Rajat Mukherjee PhD
Juha M. Kortelainen MSc
Harri Pölönen PhD
Michael Jedwab PhD
Susan L. Brady DHEd, CCC-SLP, BCS-S
Kayla Brinkman Theimer MA, CCC-SLP
Susan Langmore PhD, CCC-SLP, BCS-S
707C. M. Steele et al.: Development of a Non-invasive Device for Swallow Screening in Patients at Risk of Oropharyngeal…
1 3
Luis F. Riquelme PhD, CCC-SLP, BCS-S
Nancy B. Swigert MA, CCC-SLP, BCS-S
Philip M. Bath MD
Larry B. Goldstein MD
Richard L. Hughes MD
Dana Leifer MD
Kennedy R. Lees MD
Atte Meretoja MD, PhD
Natalia Muehlemann MD
Affiliations
Catriona M. Steele1,2  · Rajat Mukherjee3 · Juha M. Kortelainen4 · Harri Pölönen4 · Michael Jedwab5 · 
Susan L. Brady6 · Kayla Brinkman Theimer7 · Susan Langmore8 · Luis F. Riquelme9,10 · Nancy B. Swigert11,12 · 
Philip M. Bath13 · Larry B. Goldstein14 · Richard L. Hughes15 · Dana Leifer16 · Kennedy R. Lees17 · Atte Meretoja18 · 
Natalia Muehlemann5
1 Swallowing Rehabilitation Research Laboratory, Toronto 
Rehabilitation Institute – University Health Network, 550 
University Avenue, 12th floor, Toronto M5G2A2, Canada
2 Department of Speech-Language Pathology, Rehabilitation 
Sciences Institute, Faculty of Medicine, University 
of Toronto, Toronto, Canada
3 Cytel, Cambridge, MA, USA
4 VTT, Espoo, Finland
5 Medical Devices, Nestlé Health Science, Lausanne, 
Switzerland
6 Marianjoy Rehabilitation Hospital, Wheaton, IL, USA
7 Regions Hospital, St. Paul, MN, USA
8 Boston Medical Center, Boston, MA, USA
9 New York-Presbyterian Brooklyn Methodist Hospital, 
Brooklyn, NY, USA
10 Department of Speech-Language Pathology, New York 
Medical College, Valhalla, NY, USA
11 Baptist Health Lexington, Lexington, KY, USA
12 Swigert & Associates, Inc., Biltmore Lake, NC, USA
13 Division of Clinical Neuroscience, Stroke Trials Unit, 
University of Nottingham, Nottingham, UK
14 Department of Neurology, University of Kentucky, 
Lexington, KY, USA
15 Department of Neurology, University of Colorado Denver, 
Denver, CO, USA
16 Department of Neurology, Weill Cornell Medical College, 
New York, NY, USA
17 Institute of Cardiovascular and Medical Sciences, University 
of Glasgow, Glasgow, UK
18 Department of Neurology, Helsinki University Hospital, 
Helsinki, Finland
